2021
|
Sign up to set email alerts
Inhaled nitric oxide improves ventilatory efficiency and exercise capacity in patients with mild COPD: A randomized‐control cross‐over trial
Abstract: Key points Patients with mild chronic obstructive pulmonary disease (COPD) have an elevated ventilatory equivalent to CO2 production (V̇E/V̇normalCO2) during exercise, secondary to increased dead space ventilation. The reason for the increased dead space is unclear, although pulmonary microvascular dysfunction and the corresponding capillary hypoperfusion is a potential mechanism. Despite emerging evidence that mild COPD is associated with pulmonary microvascular dysfunction, limited research has focused on e… Show more
Search citation statements
Order By: Relevance
Paper Sections
Select...
38
13
5
3
Citation Types
4
62
0
0
Year Published
Range
2021
20212026
2026Publication Types
Select...
46
2
2
Relationship
10
40
Authors
Journals
Cited by 50 publications
(66 citation statements)
References 53 publications
4
62
0
0
Order By: Relevance
Smart CitationsHow the paper below cites the one you are viewing
“…We obtained satisfactory RVSP readings in 26 participants, whereas tricuspid regurgitant jet could not be estimated in the remaining participants either due to absence of tricuspid regurgitation, or technical difficulties. Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography.…”
Section: Discussion
supporting
confidence: 89%
“…Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography. Combined, these findings suggest that lowering RVSP (and likely right ventricular afterload) does not directly translate to an improvement in cardiac output at rest or during exercise.…”
Section: Discussion
supporting
confidence: 89%
“…We have previously demonstrated that iNO improves V o 2 peak in patients without hypoxemia with mild COPD and no evidence of PH secondary to reduced and dyspnea. 6 This previously reported reduction in during submaximal exercise without changes in airway mechanics or peripheral oxygen saturation supports a reduction in physiological dead space ventilation with iNO. Few studies have evaluated the effects of selective inhaled pulmonary vasodilators on V o 2 peak, ventilation, and dyspnea in patients with mild-to-severe COPD without hypoxemia or PH.…”
Section: Discussion
supporting
confidence: 55%
Smart CitationsHow the paper below cites the one you are viewing
“…We obtained satisfactory RVSP readings in 26 participants, whereas tricuspid regurgitant jet could not be estimated in the remaining participants either due to absence of tricuspid regurgitation, or technical difficulties. Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography.…”
Section: Discussion
supporting
confidence: 89%
“…Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography. Combined, these findings suggest that lowering RVSP (and likely right ventricular afterload) does not directly translate to an improvement in cardiac output at rest or during exercise.…”
Section: Discussion
supporting
confidence: 89%
“…We have previously demonstrated that iNO improves V o 2 peak in patients without hypoxemia with mild COPD and no evidence of PH secondary to reduced and dyspnea. 6 This previously reported reduction in during submaximal exercise without changes in airway mechanics or peripheral oxygen saturation supports a reduction in physiological dead space ventilation with iNO. Few studies have evaluated the effects of selective inhaled pulmonary vasodilators on V o 2 peak, ventilation, and dyspnea in patients with mild-to-severe COPD without hypoxemia or PH.…”
Section: Discussion
supporting
confidence: 55%
Smart CitationsHow the paper below cites the one you are viewing
“…As previously reported, both groups (COPD and control) frequently selected work/effort descriptors, whereas COPD patients were more likely to select UI descriptors (6,10,11,28). In COPD, UI was the only variable consistently included in models to determine the odds ratio of critical inspiratory constraint and low V˙O 2peak during CPET.…”
Section: Methods
supporting
confidence: 70%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…It is possible that individuals with tricuspid regurgitation, particularly those with excellent, but trivial, tricuspid regurgitation necessary for inclusion in this study, may have phenotypic differences in their pulmonary vasculature and a difference in their response to NO compared to individuals without tricuspid regurgitation or disease populations. While older populations and those with respiratory conditions may show a slightly greater reduction in PASP with inhaled NO in comparison to health (Brotto et al., 2022; Phillips et al., 2021), the current study demonstrates that the large change in PASP following a single rapid, deep inhalation, is far greater than any vasodilatory effect from a single inhalation of NO. Further, a validation study comparing D L,NO to D L,CO conducted in a similar sample found a strong, linear relationship between the two measures ( r 2 = 0.91, standard error of the estimate = 0.04) suggesting minimal effect of NO on diffusing capacity (Zavorsky et al., 2004).…”
Section: Discussion
mentioning
confidence: 44%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…We obtained satisfactory RVSP readings in 26 participants, whereas tricuspid regurgitant jet could not be estimated in the remaining participants either due to absence of tricuspid regurgitation, or technical difficulties. Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography.…”
Section: Discussion
supporting
confidence: 89%
“…Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography. Combined, these findings suggest that lowering RVSP (and likely right ventricular afterload) does not directly translate to an improvement in cardiac output at rest or during exercise.…”
Section: Discussion
supporting
confidence: 89%
“…We have previously demonstrated that iNO improves V o 2 peak in patients without hypoxemia with mild COPD and no evidence of PH secondary to reduced and dyspnea. 6 This previously reported reduction in during submaximal exercise without changes in airway mechanics or peripheral oxygen saturation supports a reduction in physiological dead space ventilation with iNO. Few studies have evaluated the effects of selective inhaled pulmonary vasodilators on V o 2 peak, ventilation, and dyspnea in patients with mild-to-severe COPD without hypoxemia or PH.…”
Section: Discussion
supporting
confidence: 55%
Smart CitationsHow the paper below cites the one you are viewing
“…As previously reported, both groups (COPD and control) frequently selected work/effort descriptors, whereas COPD patients were more likely to select UI descriptors (6,10,11,28). In COPD, UI was the only variable consistently included in models to determine the odds ratio of critical inspiratory constraint and low V˙O 2peak during CPET.…”
Section: Methods
supporting
confidence: 70%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…It is possible that individuals with tricuspid regurgitation, particularly those with excellent, but trivial, tricuspid regurgitation necessary for inclusion in this study, may have phenotypic differences in their pulmonary vasculature and a difference in their response to NO compared to individuals without tricuspid regurgitation or disease populations. While older populations and those with respiratory conditions may show a slightly greater reduction in PASP with inhaled NO in comparison to health (Brotto et al., 2022; Phillips et al., 2021), the current study demonstrates that the large change in PASP following a single rapid, deep inhalation, is far greater than any vasodilatory effect from a single inhalation of NO. Further, a validation study comparing D L,NO to D L,CO conducted in a similar sample found a strong, linear relationship between the two measures ( r 2 = 0.91, standard error of the estimate = 0.04) suggesting minimal effect of NO on diffusing capacity (Zavorsky et al., 2004).…”
Section: Discussion
mentioning
confidence: 44%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…We obtained satisfactory RVSP readings in 26 participants, whereas tricuspid regurgitant jet could not be estimated in the remaining participants either due to absence of tricuspid regurgitation, or technical difficulties. Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography.…”
Section: Discussion
supporting
confidence: 89%
“…Although we were not able to estimate RVSP during exercise, we observed a significant reduction in resting RVSP with iNO in the supine posture, similar to others, 6 , 9 , 22 , 47 confirming effective pulmonary vasodilation. Consistent with previous work in COPD, 6 , 48 our analyses revealed no effect of iNO on cardiac output at rest or during exercise from impedance cardiography. Combined, these findings suggest that lowering RVSP (and likely right ventricular afterload) does not directly translate to an improvement in cardiac output at rest or during exercise.…”
Section: Discussion
supporting
confidence: 89%
“…We have previously demonstrated that iNO improves V o 2 peak in patients without hypoxemia with mild COPD and no evidence of PH secondary to reduced and dyspnea. 6 This previously reported reduction in during submaximal exercise without changes in airway mechanics or peripheral oxygen saturation supports a reduction in physiological dead space ventilation with iNO. Few studies have evaluated the effects of selective inhaled pulmonary vasodilators on V o 2 peak, ventilation, and dyspnea in patients with mild-to-severe COPD without hypoxemia or PH.…”
Section: Discussion
supporting
confidence: 55%
Smart CitationsHow the paper below cites the one you are viewing
“…As previously reported, both groups (COPD and control) frequently selected work/effort descriptors, whereas COPD patients were more likely to select UI descriptors (6,10,11,28). In COPD, UI was the only variable consistently included in models to determine the odds ratio of critical inspiratory constraint and low V˙O 2peak during CPET.…”
Section: Methods
supporting
confidence: 70%
Abstract
Smart CitationsHow the paper below cites the one you are viewing
“…It is possible that individuals with tricuspid regurgitation, particularly those with excellent, but trivial, tricuspid regurgitation necessary for inclusion in this study, may have phenotypic differences in their pulmonary vasculature and a difference in their response to NO compared to individuals without tricuspid regurgitation or disease populations. While older populations and those with respiratory conditions may show a slightly greater reduction in PASP with inhaled NO in comparison to health (Brotto et al., 2022; Phillips et al., 2021), the current study demonstrates that the large change in PASP following a single rapid, deep inhalation, is far greater than any vasodilatory effect from a single inhalation of NO. Further, a validation study comparing D L,NO to D L,CO conducted in a similar sample found a strong, linear relationship between the two measures ( r 2 = 0.91, standard error of the estimate = 0.04) suggesting minimal effect of NO on diffusing capacity (Zavorsky et al., 2004).…”
Section: Discussion
mentioning
confidence: 44%
Abstract